Severity of bulimia nervosa and its impact on treatment outcome

  • Antonios DakanalisEmail author
  • Santino Gaudio
  • Giuseppe Riva
  • Massimo Clerici

Despite the burgeoning research in the aetiology of bulimic pathology, bulimia nervosa (BN) remains a serious eating disorder (ED) condition characterized by severe comorbid psychopathology, psychosocial impairment, and significant rates of medical complications [1, 2, 3, 4, 5, 6, 7, 8], underscoring the need for successful treatment options [2, 4]. Several systematic and meta-analytic reviews of the literature have given an important update on the extant treatments of BN [2, 9, 10, 11], also outlining the evidence about predictors of treatment outcome [11, 12, 13]. These valuable reviews can possibly be complemented by recent empirical evidence on the severity of BN, as defined by the most recent (fifth) edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [14], and its impact on treatment outcome.

BN is characterized by substantial within-diagnosis phenotypical heterogeneity, such that different individuals with the same disorder may exhibit variation in terms...


Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.


  1. 1.
    Culbert KM, Racine SE, Klump KL (2015) Research review: what we have learned about the causes of eating disorders–a synthesis of sociocultural, psychological, and biological research. J Child Psychol Psychiatry 56:1141–1164. doi: 10.1111/jcpp.12441 CrossRefGoogle Scholar
  2. 2.
    Mitchell JE, Agras S, Wonderlich S (2007) Treatment of bulimia nervosa: where are we and where are we going? Int J Eat Disord 40:95–101. doi: 10.1002/eat.20343 CrossRefGoogle Scholar
  3. 3.
    Dakanalis A, Carrà G, Calogero R, Zanetti MA, Gaudio S, Caccialanza R, Riva G, Clerici M (2015) Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: a multi-study. Eur Arch Psychiatry Clin Neurosci 265(8):663–776. doi: 10.1007/s00406-014-0560-2 CrossRefGoogle Scholar
  4. 4.
    Keel PK, Brown TA (2010) Update on course and outcome in eating disorders. Int J Eat Disord 43:195–204. doi: 10.1002/eat.20810 CrossRefGoogle Scholar
  5. 5.
    Dakanalis A, Clerici M, Caslini M, Gaudio S, Serino S, Riva G, Carrà G (2016) Predictors of initiation and persistence of recurrent binge eating and inappropriate weight compensatory behaviors in men. Int J Eat Disord 49(6):581–590. doi: 10.1002/eat.22535 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dakanalis A, Carrà G, Timko A, Volpato C, Pla-Sanjuanelo J, Zanetti A, Clerici M, Riva G (2015) Mechanisms of influence of body checking on binge eating. Int J Clin Health Psychol 15(2):93–104. doi: 10.1016/j.ijchp.2015.03.003 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ágh T, Kovács G, Supina D, Pawaskar M, Herman BK, Vokó Z, Sheehan DV (2016) A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eat Weight Disord 21(3):353–364. doi: 10.1007/s40519-016-0264-x CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Steinhausen H, Weber S (2009) The outcome of bulimia nervosa: findings from one-quarter century of research. Am J Psychiatry 166:1331–1341. doi: 10.1176/appi.ajp.2009.09040582 CrossRefGoogle Scholar
  9. 9.
    Kass AE, Kolko RP, Wilfley DE (2013) Psychological treatments for eating disorders. Curr Opin Psychiatry 26(6):549–555. doi: 10.1097/YCO.0b013e328365a30e CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM (2007) Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 40(4):321–336. doi: 10.1002/eat.20372 CrossRefPubMedGoogle Scholar
  11. 11.
    Thompson-Brenner H, Glass S, Weston D (2003) A multidimensional meta-analysis of psychotherapy for bulimia nervosa. Clin Psychol Sci Pract 10(3):269–287. doi: 10.1093/clipsy.bpg024 CrossRefGoogle Scholar
  12. 12.
    Vall E, Wade TD (2015) Predictors of treatment outcome in individuals with eating disorders: a systematic review and meta-analysis. Int J Eat Disord 48(7):946–971. doi: 10.1002/eat.22411 CrossRefPubMedGoogle Scholar
  13. 13.
    Berkman ND, Lohr KN, Bulik CM (2007) Outcomes of eating disorders: a systematic review of the literature. Int J Eat Disord 40:293–309. doi: 10.1002/eat.20369 CrossRefGoogle Scholar
  14. 14.
    American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, WashingtonCrossRefGoogle Scholar
  15. 15.
    Dakanalis A, Bartoli F, Caslini M, Crocamo C, Zanetti MA, Riva G, Clerici M, Carrà G (2016) Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment. Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-016-0712-7 CrossRefPubMedGoogle Scholar
  16. 16.
    Dakanalis A, Clerici M, Riva G, Carrà G (2017) Testing the DSM-5 severity indicator for bulimia nervosa in a treatment-seeking sample. Eat Weight Disord 22(1):161–167. doi: 10.1007/s40519-016-0324-2 CrossRefGoogle Scholar
  17. 17.
    National Institute for Clinical Excellence (2017) Eating disorders: recognition and treatment. British Psychological Society and Gaskell. Accessed 5 July 2017
  18. 18.
    Dakanalis A, Clerici M (2017) Response to the best available treatment for bulimia nervosa and binge-eating disorder is disease severity-dependent. Aust N Z J Psychiatry. doi: 10.1177/0004867417720518 (Epub ahead of print) CrossRefPubMedGoogle Scholar
  19. 19.
    Smith KE, Ellison JM, Crosby RD, Engel SG, Mitchell JE, Crow SJ, Peterson CB, Le Grange D, Wonderlich SA (2017) The validity of DSM-5 severity specifiers for anorexia nervosa, bulimia nervosa, and binge-eating disorder. Int J Eat Disord. doi: 10.1002/eat.22739 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    American Psychiatric Association (2006) Treatment of patients with eating disorders, third edition. Am J Psychiatry 163(7 Suppl):4–54Google Scholar
  21. 21.
    Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force On Eating Disorders (2011) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 12(6):400–443. doi: 10.3109/15622975.2011.602720 CrossRefPubMedGoogle Scholar
  22. 22.
    Walsh BT, Agras WS, Devlin MJ, Fairburn CG, Wilson GT, Kahn C, Chally MK (2000) Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am J Psychiatry 157(8):1332–1334. doi: 10.1176/appi.ajp.157.8.1332 CrossRefPubMedGoogle Scholar
  23. 23.
    Mitchell JE, Roerig J, Steffen K (2013) Biological therapies for eating disorders. Int J Eat Disord 46(5):470–477. doi: 10.1002/eat.22104 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Medicine and SurgeryUniversity of Milano-BicoccaMonzaItaly
  2. 2.Department of Brain and Behavioral SciencesUniversity of PaviaPaviaItaly
  3. 3.Department of Neuroscience, Functional PharmacologyUppsala UniversityUppsalaSweden
  4. 4.Applied Technology for Neuro-Psychology LaboratoryIRCSS Istituto Auxologico ItalianoMilanItaly
  5. 5.Department of PsychologyCatholic University of MilanMilanItaly

Personalised recommendations